Development and characterization of hydralazine mouth dissolving tablet
Keywords:
Hydralazine, Resinate, Disintegration, DissolutionAbstract
Tablet dosage form is the most popular among all existing conventional dosage forms because of its convenience of self-administration, compactness and easy manufacturing. Many patients find it difficult to swallow tablets and capsules. The difficulty is experienced in particular by pediatric and geriatric patients, but it also applies to people who are ill on bed and to those active working patients who are busy or traveling, especially those who have no access to water. The drug hydralazine HCl were used. The amount of drug was 35 mg. the different super disintegrates was used to make a suitable mouth dissolving tablet. All the other reagents which is used in analytical grade reagents. In the present study mouth dissolving tablets of hydralazine HCl were designed, prepared and evaluated. These tablets can disintegrate or dissolve rapidly once placed into the oral cavity. The feofenadine was analyzed for its organoleptic, physicochemical and spectral (IR, UV) properties. The obtained hydralazine HCl was concordant with reference specifications. A complex of hydralazine HCl was successfully formulated. The volunteers rated the resinate as tasteless and agreeable complex.
Downloads
References
Agrawal VA, Rajurkar RM, Thonte S and Ingale RG: Fast disintegrating tablets as a new drug delivery system: a review. Pharmacopohore (An International Research Journal) 2011; 2(1): 1-8.
Alebiowu G and Itiola OA: The Influence of pregelatinized starch disintegrants on interacting variables that act on disintegrant properties. Pharmaceutical Technology 2003; 28-33.
Amir, . F., Suhron, M., & Sulaihah, S. (2021). Family care model development in treating schizophrenia patients that have self-deficit nursing based system: Structural equation modeling analysis. International Journal of Health & Medical Sciences, 5(1), 7-14. https://doi.org/10.21744/ijhms.v5n1.1808
Bagul U. et. al. Manufacturing technologies for mouth dissolving tablets. www.pharmainfo.net, 2006; May 31,
Bandari S, Mittapalli RK, Gannu R and Rao YM: Orodispersible tablets: an Asian Journal of Pharmaceutics 2008; 2(1): 2-11.
Bhowmik D, Chiranjib B, Yadav J, Chandira RM and Kumar S: Emerging trends of disintegrants used in formulation of solid dosage form. Scholars Research Library Der Pharmacia Lettre 2010; 2 (1): 495-504.
Biradar S, Bhagavati S and Kuppasad. Fast dissolving drug delivery system: a brief overview. Internet J. Pharmcol. 2006; 4(2).
Blank R, Mody D, Kenny R and Avenson M. Fast dissolving dosage form. United States Patent 4,946,684. 7th August 1990.
Camarco W, Ray D and Druffner A: Selecting superdisintegrants for orally disintegrating tablet formulations. Pharmaceutical Technology Supplement 2006.
Chang R, Guo X, Burnside BA, Couch RA. Fast Dissolving Tablets. Pharmaceutical Technology 2000; 24(6):52-58.
Cousin G, Bruna E, Gendrot E. Rapidly Disintegratable Multiparticular Tablet. US Patent 5,464,632; 1995.
European Directorate for the Quality of Medicine 1988. Pharmeurope, 10(4): 547.
Ghosh T, Ghosh A and Prasad D: A review on new generation orodispersible tablets and its future prospective. International Journal of Pharmacy and Pharmaceutical Sciences 2011; 3(1): 1-7.
Giri TK, Tripathi DK and Majumdar R: Formulation aspects in the development of orodispersible tablets: an overview. International Journal of Pharmacy and Pharmaceutical Sciences 2010; 2(3): 38-42.
Goel H, Vora N and Rana V: A novel approach to optimize and formulate fast disintegrating tablets for nausea and vomiting. AAPS PharmSciTech 2008; 9(3): 774-781.
Habib W, Khankari R and Hontz J. Fast-dissolve drug delivery system. Crit. Rev. Ther. Drug Carrier Syst. 2000; 17:61-72.
Hirani JJ, Rathod DA and Vadalia RK: Orally disintegrating tablets: a review. Tropical Journal of Pharmaceutical Research 2009; 8(2): 161-172.
Konapure AS, Chaudhari PS, Oswal RJ, Kshirsagar SS, Antre RV and Chorage TV: Mouth dissolving tablets-an innovative technology. International Journal of Applied Biology and Pharmaceutical Technology 2011; 2(1): 496-503.
Kuchekar BS, Badhan C, Mahajan HS. Mouth Dissolving Tablets: A Novel Drug Delivery System. Pharma Times 2003; 35:7-9.
Kumar MV, Sethi P, Kheri R, Saraogi GK and Singhai AK: Orally disintegrating tablets: a review. International Research Journal of Pharmacy 2011; 2(4): 16-22.
Mizumoto T, Masuda Y, Kajiyama A, Yanagisawa M, Nyshadham JR. Tablets Quickly Disintegrating in the Oral Cavity and Process for Producing the Same. US Patent 6,589,554; 2003.
Mohanachandran PS, Sindhumol PG and Kiran TS: Superdisintegrants: an overview. Journal of Pharmaceutical Sciences Review and Research 2011; 6(1): 105-109.
Pahwa R, Piplani M, Sharma PC, Kaushik D and Nanda S: Orally disintegrating tablets – friendly to pediatrics and geriatrics. Archives of Applied Science Research 2010; 2(2): 35-48.
Reilly W.J.; Remington: The Science and Practice of Pharmacy, 20th edition, Mack publishing company, 2002, PP 1018-1020.
Seager H. Drug-delivery products and the Zydis fast-dissolving dosage, J Pharm Pharmacol. 1998 Apr; 50(4):375-82.
Siddiqui Md.N, Garg G and Sharma PK: Fast Dissolving Tablets: Preparation, Characterization and Evaluation: an overview. International Journal of Pharmaceutical Sciences Review and Research 2010; 4(2): 87-96.
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Get vaccinated when it is your turn and follow the local guidelines. International Journal of Health Sciences, 5(3), x-xv. https://doi.org/10.53730/ijhs.v5n3.2938
Vaibhav S, Mahaveer PK, Gupta MK, Agarwal D and Sharma N: Orally disintegrating tablet: friendly dosage form. International Journal of Research in Ayurveda and Pharmacy 2010; 1(2): 399-407.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
